How I can participate or register in the Project Twenty21 clinical trial in the UK? UKs largest medical cannabis patient trial ever

Andy

New member
Apr 14, 2019
21
28
3
Project TWENTY21 will enrol 20,000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis – with an aim to demonstrate to policymakers that medical cannabis should be as widely available, and affordable, as other approved medicines for patients who would benefit from them.

It will also support prescribers across the country to feel confident in providing medical cannabis to patients. We hope that the findings will make a powerful case for NHS funding, by proving the favourable risk/benefit ratio of medical cannabis in seven key identified conditions. In the first instance, this real-world registry will be targeting the following patients and situations, specifically focusing on those in which alternative treatment has failed:
  • Anxiety Disorder
  • Chronic Pain
  • Epilepsy
  • Multiple Sclerosis (MS)
  • Post Traumatic Stress Disorder (PTSD)
  • Substance Use Disorder (as a harm reduction strategy)
  • Tourette’s Syndrome
Treatment will be provided at a network of clinics across the UK which utilise best-practice in medical cannabis treatment from recognised global leaders in medical cannabis, including Canada and Australia.

Just enter you name and email here and you will be contacted by Twenty21 trial team:
https://drugscience.org.uk/project-twenty21/
 
  • Like
Reactions: Alexander and Ivan

Ivan

New member
May 2, 2019
10
8
3
Project TWENTY21 will enrol 20,000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis – with an aim to demonstrate to policymakers that medical cannabis should be as widely available, and affordable, as other approved medicines for patients who would benefit from them.

It will also support prescribers across the country to feel confident in providing medical cannabis to patients. We hope that the findings will make a powerful case for NHS funding, by proving the favourable risk/benefit ratio of medical cannabis in seven key identified conditions. In the first instance, this real-world registry will be targeting the following patients and situations, specifically focusing on those in which alternative treatment has failed:
  • Anxiety Disorder
  • Chronic Pain
  • Epilepsy
  • Multiple Sclerosis (MS)
  • Post Traumatic Stress Disorder (PTSD)
  • Substance Use Disorder (as a harm reduction strategy)
  • Tourette’s Syndrome
Treatment will be provided at a network of clinics across the UK which utilise best-practice in medical cannabis treatment from recognised global leaders in medical cannabis, including Canada and Australia.

Just enter you name and email here and you will be contacted by Twenty21 trial team:
https://drugscience.org.uk/project-twenty21/
I just signed up, it is a really easy process to follow
 
  • Like
Reactions: Andy

Alexander

Administrator
Staff member
Mar 28, 2019
109
72
28
it is really heartbreaking seeing how difficult getting medical CBD or medical cannabis in the UK on prescription. Hopefully with this and other trials medical cannabis would become available to all those who really need it.